| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 May 2026 | 21 Apr 2026 |
| Final Dividend & Audited Results Investor Presentation on Q4FY26 Financial Results Board approves final dividend of Rs. 20/- per share, subject to approval of shareholders in the ensuing 48th AGM (As Per BSE Annoncement Dated on:15.05.2026) | ||
| Board Meeting | 9 Apr 2026 | 9 Apr 2026 |
| Board Meeting Outcome for Reappointment Of Ms. Naina Lal Kidwai As An Independent Director, Subject To Shareholders Approval | ||
| Board Meeting | 28 Jan 2026 | 9 Jan 2026 |
| Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31, 2025 Unaudited Financial results for the quarter and nine months ended December 31, 2025 Outcome of Board Meeting held on January 28, 2026 (As Per BSE Announcement Dated on 28.01.2026) | ||
| Board Meeting | 3 Nov 2025 | 17 Oct 2025 |
| Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2025 Unaudited Financial Results for the quarter and half year ended September 30, 2025 (As per BSE Announcement dated on: 03.11.2025) | ||
| Board Meeting | 5 Aug 2025 | 21 Jul 2025 |
| Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve standalone and consolidated financial results for the quarter ended June 30 2025. Unaudited Financial Results for the Quarter ended June 30, 2025 (As Per BSE Announcement Dated on: 05/08/2025) | ||
The European business reported a 54 percent year on year surge in topline during the quarter.
Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.
Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.
The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.
Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.
Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.
Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.
Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US
The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
